EUCTR2004-004514-17-SEActive, not recruitingNot Applicable
Does Acamprosate Decrease Cue-induced Alcohol Craving? - DADCAC
Beroendcentrum Stockholm0 sitesStarted: December 22, 2004Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •To be included, the patients are supposed to: 1) be a male or a non-pregnant/non-nursing female between 18 and 65 years of age. 2) have a goal of controlled drinking. 3) have an intact sense of smell. 4) fulfill the criteria for alcohol dependence according to DSM-IV. 5) be willing to give informed consent and comply with study procedures. 6) have consumed alcohol in 12 days of the last 12 weeks.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •To be included, the patients may not: 1) be seeking complete alcohol abstinence. 2) have a current use of any medication that interferes with salivation. 3) have a serious medical condition. 4) have a diagnosis of an Axis I psychiatric disorder according to DSM-IV criteria (including all forms of substance dependence other than nicotine and alcohol). 5) have a current use of psychoactive medications to manage schizophrenia, bipolar disorder, or major depression. 6) have been abstinent from alcohol for 30 days or more. 7) have received inpatient alcohol detoxification within the last 4 days. 8) Have been treated with acamprosate for the last year. 9) Have used any illegal drugs for the last 30 days. 10) Use illegal drugs during the course of the study.
Investigators
Similar Trials
Completed
Phase 2
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified AlcoholicsAlcoholismNCT00605904National Institute on Alcohol Abuse and Alcoholism (NIAAA)37
Terminated
Phase 4
Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice SuperviseesAlcohol DependenceNCT00249379Virginia Commonwealth University26
Completed
Phase 4
Acamprosate in Alcoholics With Comorbid Anxiety or DepressionMajor DepressionGeneralized Anxiety DisorderAlcohol DependenceSocial Anxiety DisorderNCT00330174Medical University of South Carolina90
Completed
Phase 1
Open Label Trial of Acamprosate in Bipolar AlcoholicsBipolar DisorderAlcohol DependenceNCT00330486Medical University of South Carolina9
Completed
Phase 2
Acamprosate Treatment: Mechanisms of ActionAlcoholismNCT00004552Yale University120